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INTRODUCTION:  Aggressive  angiomyxoma  is a rare  mesenchymal  tumor  occurring  predominantly  in  the
pelvi-perineal  region.  It  is  more  common  in  females  during  their  reproductive  age.  Our  focus  is  on the
surgical  approach  for a recurrent  angiomyxoma.
CASE  PRESENTATION:  We  present  a case  of a  36-year-old  female  patient  with  a  recurrent  lower  back  and
perineal bulges.  One year  ago,  she  had  the  same  presentation  and  underwent  resection  of  that  mass
in  a peripheral  hospital  without  available  information.  Five  months  later,  she  started  to have  the  same
bulge.  Computed  tomography  scan  and  true  cut  biopsy  were  suggestive  of angiomyxoma  with  single  lung
metastasis.  The decision  was  to  proceed  with  resection  through  a  transabdominal  and  perineal  incision,
even  in the presence  of  metastasis  since  it’s a very  slow  growing  tumor  with  long  life expectancy.  The
pathology  was consistent  with  aggressive  angiomyxoma.
DISCUSSION: 90%  of  patients  with  angiomyxoma  are  women.  Although  it is benign,  the  tumor  is still
aggressive  because  of  the  high  rate  of  local  recurrence  after  resection.  Angiomyxoma  is a mesenchymal
tumor,  composed  of  ﬁbroblasts  within  a myxoid  background.  Treatment  is  usually  through  wide  local
excision  to  achieve  an  R0  resection.  Our  approach  was  through  a  transabdominal  and perineal  incision,
which  allowed  full control  and mobilization  of  the  tumor  without  disrupting  the capsule.  This  surgical
approach  was not  described  previously  in  the  literature.
CONCLUSION:  The  principle  to  achieve  cure  in  aggressive  angiomyxoma  is  by  optimizing  exposure  through
two different  incisions,  wide  excision  while  keeping  the  capsule  intact  and removing  enbloc  any  invaded
organ.
© 2016  The  Authors.  Published  by  Elsevier  Ltd  on  behalf  of  IJS Publishing  Group  Ltd.  This is  an  open
he  CCaccess  article  under  t
. Introduction
Angiomyxoma is an uncommon mesenchymal neoplasm occur-
ing predominantly in the pelvi-perineal region of adults [1,2]. The
ajority of patients are female in the productive age group [3].
lthough it is benign, the tumor is considered an aggressive tumor
econdary to its high rate of local recurrence. Most of the cases
ill recur in 2 years post resection. Complete resection with an
ttempt of a resection margin (R0) should be the aim of the surgery
o decrease the rate of recurrence. Our patient is a 36 year old female
atient who presented with a recurrent lower back bulge along
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with perineal bulge. Surgery was  performed successfully with an
abdomino-perineal approach.
2. Materials and methods
A 36 year old female patient presented to our institution with
a recurrent lower back bulge along with perineal bulge. One year
ago, she had the same presentation and she underwent surgery
and resection of that mass in a peripheral hospital. There was  no
available information regarding the pathology of neither that mass
nor the surgical details. Five month later she started to have same
bulge associated with pelvic heaviness and urinary urgency. Phys-
ical examination revealed a non-tender diffuse ﬁrm and dull mass
over lower back more on the right extending to right perineal area.
Computed tomography scan of chest, abdomen and pelvis revealed
a 20 cm right pelvic mass extending to right ischiorectal fossa and
inferior aspect of right perineum with no deﬁnite invasion to rec-
roup Ltd. This is an open access article under the CC BY-NC-ND license (http://
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emonstrating the extension of the angiomyxoma down to the pelvis.
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tFig. 1. CT scan of the abdomen and pelvis: a ﬁgure of a CT scan d
um; uterus or bladder (Fig. 1). Chest scan revealed a single lung
etastasis. True cut biopsy revealed angiomyxoma, so decision was
o proceed with resection even in the presence of lung metastasis
aking into consideration that since it is a very slow growing tumor
ith long life expectancy. That decision was backed up by several
ases reported in the literature where resection was  performed in
he presence of metastases [4].
The aim of our surgery was to achieve an R0 resection, the sur-
ical approach was through a transabdominal and perineal incision
Fig. 2). These two incisions will allow a full control and mobiliza-
ion of the tumor without disrupting the capsule if present. This
urgical approach was not described previously in the literature.
The transabdominal incision was used to get access to the tumor
nteriorly and to dissect it away from the rectum, bladder, uterus
nd the ureters. The tumor was not found to be invading those
tructures. After full dissection in the pelvis and mobilization of
he tumor, the perineum attachment of the tumor was not acces-
ible through this incision. So another incision was made in the
erineal triangle posteriorly to avoid damaging the urethra that
s present in the anterior triangle. The incision was  made lateral
o anus in the ischiorectal fossa and lateral to the anal sphincter
uscles to avoid incontinence (Fig. 3). The dissection was carried
edialy and away from the ischial tuberosity to keep the dissection
edial to sacrotuberous ligament and to avoid damaging the struc-ures that emerge lateral and under this ligament (pudundal bundle
nd sciatic nerve). After the dissection in the ischiorectal fossa was
ompleted, the pelvic ﬂoor muscles were split and exposure of the
umor was achieved. The tumor was not found to be invading the
Fig. 3. Perineal incision and approach: a ﬁgure demFig. 2. Abdominal and perineal approach: a ﬁgure demonstrating both the abdom-
inal and perineal incisions performed.pelvic ﬂoor muscles so it was resected and was  fully mobilized and
was extracted from the perineal incision (Fig. 4). Since the tumor
was intact seeding at the extraction site was not a concern. Most of
onstrating the perineal incision performed.
CASE  REPORT  –  O
W.  Faraj et al. / International Journal of Surg
F
d
r
r
3
c
t
a
a
4
p
a
o
c
e
T
a
A
o
7
t
H
ﬁ
t
m
b
a
dig. 4. Delivery of the specimen through the perineum: a ﬁgure demonstrating the
elivery of the tumor resected through the perineal incision.
ecurrent cases and tumor seeding were secondary to incomplete
esection [1].
. Results
Pathology revealed spindled and stellate bland cells in a ﬁbro-
ollagenous and markedly myxoid stroma, immunostains show
hat tumor cells express desmin and smooth muscle actin and
re negative for S100. This pattern is consistent with aggressive
ngiomyxoma.
. Discussion
Aggressive angiomyxoma is an uncommon mesenchymal neo-
lasm occurring predominantly in the pelvi-perineal region of
dults, ﬁrst described in 1983 by Steeper and Rosai [2]. About 90%
f patients are women, usually in the reproductive age [3]. A few
ases have been described in males, usually in scrotum. On gross
xamination the tumors are lobulated, soft to rubbery, solid masses.
he gelatinous appearance, greyish discoloration on cross section
nd the large size of the tumor are common features of AAMs.
lthough it is benign, the tumor is still called aggressive because
f the high rate of local recurrence after resection. Approximately
0% of the cases locally recurred after a period of 2 years. Recurrent
umors show more prominent areas of hemorrhage and ﬁbrosis.
istologically angiomyxoma is a mesenchymal tumor, composed of
broblasts within a strong myxoid background. Vascular prolifera-
ion is also prominent, and virtually no mitoses are present. The vast
ajority of cases demonstrate positivity for desmin in the myxoid
undles and/or stromal cells, while actins and CD34 may  be vari-
bly positive. The documented studies for immunohistochemical
ata in two series showed nearly 97% positive response to desmin,PEN  ACCESS
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94% for smooth muscle actin, 93 and 90% for oestrogen and proges-
terone receptors, respectively, but 0% for S100 protein. The tumor
grows slowly, and its benign nature is suggested by the histology
and by the fact that it shows no tendency to metastasize. However,
it is locally aggressive and tends to recur (36–72%) after resection
[5].
Any attempt to fully resect the tumor and to decrease rate of
recurrence to achieve cure, should follow the three main princi-
ples; ﬁrst is to use the two incision strategy to fully expose the
tumor (transabdominal and perineal incision), second is to keep
the capsule intact, third is to remove en bloc any invaded organ.
The surgical approach used in our case allow the surgeon to fully
expose and mobilize the tumor since it is not limited to abdomen
but extend to the pelvis and down to the perineal area. The per-
ineal approach will allow proper dissection of the tumor from its
attachment to the pelvic ﬂoor. This approach should be performed
in multidisciplinary fashion especially when the surgeon is plan-
ning for excessive dissection in the perineum where urologist and
gynecologists should be on board because urinary incontinence,
ureteral, bladder and vaginal injury can occur. the main concern
of this approach as mentioned earlier is iatrogenic injury to anal
sphincters and pudendal bundle but this can be avoided by keep-
ing the dissection directly lateral to the sphincters and identify
them and also by staying medial and away as possible from the
ischial tuberosity in the posterior triangle. Agressive angiomyx-
oma  must be distinguished from other mesenchymal tumors of the
genital area which are the angiomyoﬁbroblastoma and the cellu-
lar angioﬁbroma which are well circumscribed and usually do not
recur.
On CT scan, the tumor has a well-deﬁned margin and attenu-
ation less than that of muscle. Coronal T2-weighted MR  imaging
displays a large tumor with high signal intensity interspersed with
swirled or layered strands of lower signal intensity. Treatment is
usually surgery in form of wide local excision to achieve an R0
resection.
5. Conclusion
Although a rare disease, aggressive angiomyxoma can have
unusual presentation. Detailed radiological and physical examina-
tions are helpful in suspecting the disease, but histology is gold
standard for diagnosis. The principle to achieve cure is based on
three main points; ﬁrst is optimal exposure through two different
incisions, second is Wide excision keeping the capsule intact, third
is removing enbloc any invaded organ. Follow-up with alternate
MRI  and sonographic examination at 1–2 yearly intervals should
sufﬁce.
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